311 related articles for article (PubMed ID: 28078671)
21. Combinatorial effects of azacitidine and trametinib on NRAS-mutated melanoma.
Hanft KM; Hamed E; Kaiser M; Würtemberger J; Schneider M; Pietsch T; Feige U; Meiss F; Krengel S; Niemeyer C; Hettmer S
Pediatr Blood Cancer; 2022 Apr; 69(4):e29468. PubMed ID: 34866327
[TBL] [Abstract][Full Text] [Related]
22. Great Ormond Street Hospital for Children Registry for Congenital Melanocytic Naevi: prospective study 1988-2007. Part 2--Evaluation of treatments.
Kinsler VA; Birley J; Atherton DJ
Br J Dermatol; 2009 Feb; 160(2):387-92. PubMed ID: 19016692
[TBL] [Abstract][Full Text] [Related]
23. Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi.
Rouillé T; Aractingi S; Kadlub N; Fraitag S; How-Kit A; Daunay A; Hivelin M; Moguelet P; Picard A; Fontaine RH; Guégan S
J Invest Dermatol; 2019 Sep; 139(9):2004-2015.e13. PubMed ID: 31059696
[TBL] [Abstract][Full Text] [Related]
24. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
[TBL] [Abstract][Full Text] [Related]
25. Nodular lesions arising in a large congenital melanocytic naevus in a newborn with eruptive disseminated Spitz naevi.
Feito-Rodríguez M; de Lucas-Laguna R; Bastian BC; Leboit P; González-Beato MJ; López-Gutiérrez JC; Requena L; Pizarro A
Br J Dermatol; 2011 Nov; 165(5):1138-42. PubMed ID: 21711345
[TBL] [Abstract][Full Text] [Related]
26. Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations.
Martins da Silva V; Martinez-Barrios E; Tell-Martí G; Dabad M; Carrera C; Aguilera P; Brualla D; Esteve-Codina A; Vicente A; Puig S; Puig-Butillé JA; Malvehy J
J Invest Dermatol; 2019 Apr; 139(4):900-908. PubMed ID: 30359577
[TBL] [Abstract][Full Text] [Related]
27. Core concepts in congenital melanocytic nevi and infantile hemangiomas.
Warner C; Dinulos JG
Curr Opin Pediatr; 2014 Feb; 26(1):130-5. PubMed ID: 24346182
[TBL] [Abstract][Full Text] [Related]
28. Congenital melanocytic naevi.
Kovalyshyn I; Braun R; Marghoob A
Australas J Dermatol; 2009 Nov; 50(4):231-40; quiz 241-2. PubMed ID: 19916964
[TBL] [Abstract][Full Text] [Related]
29. The risk of melanoma and neurocutaneous melanosis associated with congenital melanocytic nevi.
Shah KN
Semin Cutan Med Surg; 2010 Sep; 29(3):159-64. PubMed ID: 21051009
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and risks of large congenital melanocytic naevi: a review of 31 patients at the Sydney Children's Hospital.
Chen AC; McRae MY; Wargon O
Australas J Dermatol; 2012 Aug; 53(3):219-23. PubMed ID: 22671135
[TBL] [Abstract][Full Text] [Related]
31. Large congenital melanocytic naevi: clinical considerations based on 27 patients.
Baykal C; Kurul S
J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):241-4. PubMed ID: 12705771
[No Abstract] [Full Text] [Related]
32. [Congenital melanocytic nevi in children. The level of knowledge and management suggestions].
Wahlgren CF; Hedblad MA; Lundberg B; Larson O
Lakartidningen; 2009 Oct 21-27; 106(43):2754-7. PubMed ID: 19960901
[No Abstract] [Full Text] [Related]
33. Mosaic NRAS Q61R mutation in a child with giant congenital melanocytic naevus, epidermal naevus syndrome and hypophosphataemic rickets.
Ramesh R; Shaw N; Miles EK; Richard B; Colmenero I; Moss C
Clin Exp Dermatol; 2017 Jan; 42(1):75-79. PubMed ID: 27900779
[TBL] [Abstract][Full Text] [Related]
34. Varying proliferative and clonogenic potential in NRAS-mutated congenital melanocytic nevi according to size.
Guégan S; Kadlub N; Picard A; Rouillé T; Charbel C; Coulomb-L'Hermine A; How-Kit A; Fraitag S; Aractingi S; Fontaine RH
Exp Dermatol; 2016 Oct; 25(10):789-96. PubMed ID: 27193390
[TBL] [Abstract][Full Text] [Related]
35. Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood.
Vergier B; Laharanne E; Prochazkova-Carlotti M; de la Fouchardière A; Merlio JP; Kadlub N; Avril MF; Bodemer C; Lacoste C; Boralevi F; Taieb A; Ezzedine K; Fraitag S
JAMA Dermatol; 2016 Oct; 152(10):1147-1151. PubMed ID: 27486690
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and risk of melanoma development from giant congenital melanocytic naevi in Korea: a nationwide retrospective study.
Yun SJ; Kwon OS; Han JH; Kweon SS; Lee MW; Lee DY; Kim MB; Kim YC; Yoon TY; Chung KY; Kim IH; Kim KH; Suh KS; Lee SJ; Seo YJ; Kim KH; Park HJ; Roh MR; Ahn KJ; Yoon TJ; Kim MH; Li KS; Park JS; Shin BS; Ko JY; Ahn HH; Kim HJ; Park SD; Jang SJ; Won YH
Br J Dermatol; 2012 Jan; 166(1):115-23. PubMed ID: 21923752
[TBL] [Abstract][Full Text] [Related]
37. Current management approaches for congenital melanocytic nevi.
Krengel S; Marghoob AA
Dermatol Clin; 2012 Jul; 30(3):377-87. PubMed ID: 22800546
[TBL] [Abstract][Full Text] [Related]
38. Case reports of fatal or metastasizing melanoma in children and adolescents: a systematic analysis of the literature.
Neuhold JC; Friesenhahn J; Gerdes N; Krengel S
Pediatr Dermatol; 2015; 32(1):13-22. PubMed ID: 25487565
[TBL] [Abstract][Full Text] [Related]
39. Melanoma arising in a giant congenital melanocytic nevus with neuroblastoma RAS mutation.
Dudani P; Senthilnathan G; Wajid MA; Gupta AK; Kaushal S; Arora S; Shamim SA; Bhari N
Indian J Dermatol Venereol Leprol; 2021; 87(3):416-420. PubMed ID: 33871206
[No Abstract] [Full Text] [Related]
40. Congenital melanocytic nevi.
Moustafa D; Blundell AR; Hawryluk EB
Curr Opin Pediatr; 2020 Aug; 32(4):491-497. PubMed ID: 32692047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
